医学
冲程(发动机)
血管内治疗
护理标准
随机对照试验
缺血性中风
重症监护医学
急性中风
人口
外科
心脏病学
内科学
缺血
机械工程
组织纤溶酶原激活剂
工程类
动脉瘤
环境卫生
作者
Jin Woo Bae,Dong Keun Hyun
标识
DOI:10.3340/jkns.2023.0181
摘要
Endovascular thrombectomy (EVT) has been established as the standard of care in the treatment of acute ischemic stroke (AIS) based on landmark randomized controlled trials. Nevertheless, while the strict eligibility of EVT for AIS patients restrict the wide application of EVT, a considerable population still undergoes off-label EVT. Besides, it is important to acknowledge that recanalization is not achieved in approximately 20% of procedures, and more than 50% of patients who undergo EVT still do not experience a favorable outcome. This article reviews the brief history of EVT trials and recent progressions in the treatment of AIS, with focusing on the expanding eligibility criteria, new target for EVT, and the evolution of EVT techniques.
科研通智能强力驱动
Strongly Powered by AbleSci AI